Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma (Q39918641)

15 September 2017

Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma (English)

1 reference

15 September 2017

1 reference

Zheng Wang

1

1 reference

15 September 2017

Jian Zhou

2

1 reference

15 September 2017

Jia Fan

3

1 reference

15 September 2017

Chang-Jun Tan

4

1 reference

15 September 2017

Shuang-Jian Qiu

5

1 reference

15 September 2017

Yao Yu

6

1 reference

15 September 2017

Xiao-Wu Huang

7

1 reference

15 September 2017

Zhao-You Tang

8

1 reference

15 September 2017

11 November 2008

1 reference

Journal of Cancer Research and Clinical Oncology

15 September 2017

1 reference

15 September 2017

135

1 reference

15 September 2017

715-722

1 reference

15 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-008-0506-z

15 September 2017

0 references

cites work

Molecularly targeted therapy for gastrointestinal cancer

1 reference

12 December 2020

Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma

1 reference

12 December 2020

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

12 December 2020

Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy

1 reference

12 December 2020

Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway

1 reference

12 December 2020

Molecularly targeted therapy in renal cell carcinoma

1 reference

12 December 2020

Transforming growth factor-beta and Ras regulate the VEGF/VEGF-receptor system during tumor angiogenesis.

1 reference

12 December 2020

Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.

1 reference

12 December 2020

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

1 reference

12 December 2020

Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer

1 reference

12 December 2020

Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow

1 reference

12 December 2020

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.

1 reference

12 December 2020

Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway

1 reference

12 December 2020

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

1 reference

12 December 2020

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy

1 reference

12 December 2020

Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma

1 reference

12 December 2020

Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.

1 reference

12 December 2020

Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer

1 reference

12 December 2020

Hepatocellular carcinoma: the need for progress.

1 reference

12 December 2020

Surgical options for hepatocellular carcinoma: resection and transplantation

1 reference

12 December 2020

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.

1 reference

12 December 2020

Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma

1 reference

12 December 2020

Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues

1 reference

12 December 2020

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

12 December 2020

Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression

1 reference

12 December 2020

Rapamycin inhibits cell growth by induction of apoptosis on hepatocellular carcinoma cells in vitro

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation

1 reference

12 December 2020

Clinical pharmacokinetics of sirolimus

1 reference

12 December 2020

10.1007/S00432-008-0506-Z

Identifiers

DOI

1 reference

15 September 2017

1 reference